These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33335231)

  • 21. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
    Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).
    Huynh T; Montigny M; Iftikhar U; Gagnon R; Eisenberg M; Lauzon C; Mansour S; Rinfret S; Afilalo M; Nguyen M; Kouz S; Déry JP; Harvey R; De LaRocheliere R; Cantin B; Schampaert E; Tardif JC
    Am J Cardiol; 2018 Apr; 121(8):897-902. PubMed ID: 29452691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term prognosis of unheralded myocardial infarction vs chronic angina; role of sex and coronary atherosclerosis burden.
    Carpeggiani C; Michelassi C; Landi P; L'Abbate A
    BMC Cardiovasc Disord; 2018 Jul; 18(1):156. PubMed ID: 30064378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Coronary Intervention Is More Beneficial Than Optimal Medical Therapy in Elderly Patients with Angina Pectoris.
    Won H; Her AY; Kim BK; Kim YH; Shin DH; Kim JS; Ko YG; Choi D; Kwon HM; Jang Y; Hong MK
    Yonsei Med J; 2016 Mar; 57(2):382-7. PubMed ID: 26847290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry.
    Chung J; Han JK; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S62-S71. PubMed ID: 32615654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.
    Uretsky BF; Birnbaum Y; Osman A; Gupta R; Paniagua O; Chamoun A; Pohwani A; Lui C; Lev E; McGehee T; Kumar D; Akhtar A; Anzuini A; Schwarz ER; Wang FW
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):488-97. PubMed ID: 18814223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis.
    Park MW; Park GM; Han S; Yang Y; Kim YG; Roh JH; Park HW; Suh J; Cho YR; Won KB; Ann SH; Kim SJ; Kim DW; Her SH; Lee SG
    PLoS One; 2018; 13(12):e0207889. PubMed ID: 30532220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.
    Saluveer O; Redfors B; Angerås O; Dworeck C; Haraldsson I; Ljungman C; Petursson P; Odenstedt J; Ioanes D; Lundgren P; Völz S; Råmunddal T; Andersson B; Omerovic E; Bergh N
    Blood Press; 2017 Jun; 26(3):166-173. PubMed ID: 28092977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Percutaneous coronary intervention in addition to optimal medical therapy for stabile coronary artery disease - a systematic review and meta-analysis].
    Gorenoi V; Hagen A
    Dtsch Med Wochenschr; 2014 May; 139(20):1039-45. PubMed ID: 24801298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefit of the late percutaneous coronary intervention in the patients after acute myocardial infarction who are or who are not treated with thrombolysis.
    Knezević B; Bulatović N; Belada N; Ivanović V; Dragnić S; Rabrenović M; Nikolić G; Musić L; Bosković A
    Bosn J Basic Med Sci; 2009 Feb; 9(1):54-8. PubMed ID: 19284396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.
    Ndrepepa G; Kufner S; Mayer K; Cassese S; Xhepa E; Fusaro M; Hasimi E; Schüpke S; Laugwitz KL; Schunkert H; Kastrati A
    Cardiovasc Revasc Med; 2019 Feb; 20(2):101-107. PubMed ID: 29802021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between revascularization extent and the long-term prognosis of patients with stable angina pectoris and three-vessel disease treated by percutaneous coronary intervention in the era of drug-eluting stents.
    Li Q; Yu X; He J; Gao Y; Zhang X; Wu C; Luo Y; Zhang Y; Ren X; Lv S; Chen F
    Clin Cardiol; 2014 Sep; 37(9):566-75. PubMed ID: 25123798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manual Thrombus Aspiration Is Not Associated With Reduced Mortality in Patients Treated With Primary Percutaneous Coronary Intervention: An Observational Study of 10,929 Patients With ST-Segment Elevation Myocardial Infarction From the London Heart Attack Group.
    Jones DA; Rathod KS; Gallagher S; Jain AK; Kalra SS; Lim P; Crake T; Ozkor M; Rakhit R; Knight CJ; Iqbal MB; Dalby MC; Malik IS; Whitbread M; Mathur A; Redwood S; MacCarthy PA; Weerackody R; Wragg A
    JACC Cardiovasc Interv; 2015 Apr; 8(4):575-84. PubMed ID: 25907084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention.
    Ann SH; Strauss MH; Park GM; Han S; Yang Y; Kim YG; Won KB; Kim SJ; Lee SG; Cho YR; Kim DW; Park MW; Her SH; Lee SW
    Int J Cardiol; 2020 May; 306():35-41. PubMed ID: 31727411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.